Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1732008

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1732008

Cold Sore Treatment

PUBLISHED:
PAGES: 469 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Global Cold Sore Treatment Market to Reach US$1.3 Billion by 2030

The global market for Cold Sore Treatment estimated at US$993.0 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Topical Treatments, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$735.1 Million by the end of the analysis period. Growth in the Oral Treatments segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$270.5 Million While China is Forecast to Grow at 7.4% CAGR

The Cold Sore Treatment market in the U.S. is estimated at US$270.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$256.6 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Cold Sore Treatment Market - Key Trends & Drivers Summarized

Why Is Cold Sore Treatment a Persistent Focus in Dermatology and Antiviral Therapy?

Cold sores, caused primarily by herpes simplex virus type 1 (HSV-1), remain among the most common and recurring viral infections globally. Affecting a significant portion of the population, these lesions not only cause discomfort and aesthetic concern but also pose transmission risks. The recurrent nature of outbreaks-triggered by stress, illness, or sun exposure-has sustained long-term demand for effective treatment options that can manage symptoms, shorten episode duration, and reduce recurrence.

Despite being a non-life-threatening condition, cold sores significantly impact patient quality of life and social interactions, especially in visible or painful cases. The availability of over-the-counter (OTC) and prescription therapies, along with growing awareness of early intervention, has expanded the treatment-seeking population. As consumer health trends emphasize self-care, there is a clear shift toward fast-acting, user-friendly antiviral solutions that minimize disruption and speed healing.

How Are Therapeutic Classes and Delivery Formats Evolving to Improve Efficacy and Convenience?

Antiviral agents such as acyclovir, valacyclovir, and famciclovir continue to serve as first-line therapies, available in both topical and oral formulations. While systemic drugs are preferred for severe or frequent outbreaks, topical creams and gels offer rapid localized relief and ease of use. Recent innovations include liposomal delivery systems, hydrocolloid patches, and bioadhesive films that improve drug retention and barrier protection-enhancing treatment effectiveness at the lesion site.

Emerging delivery formats such as cold sore-specific microcurrent devices and light therapy tools are also gaining consumer interest for their potential to reduce viral replication and speed lesion resolution without pharmacological agents. These adjunctive technologies, often marketed directly to consumers, appeal to individuals seeking drug-free or combination treatments. The growth of teledermatology and e-pharmacy platforms is further supporting fast access to prescription antivirals and fueling adoption of personalized outbreak management strategies.

Which Consumer Segments and Healthcare Channels Are Driving Market Penetration?

Young adults and middle-aged populations-particularly those with high social engagement and appearance-conscious lifestyles-represent the most proactive cold sore treatment consumers. This demographic seeks early symptom control to minimize aesthetic and social disruption, often favoring rapid-onset OTC products. Increasing awareness among first-time sufferers and growing acceptance of cold sore discussions in mainstream media are also reducing stigma and expanding treatment demand among broader age groups.

Pharmacies, both retail and online, serve as the primary distribution channels, given the wide availability of OTC treatments and pharmacist-led recommendations. Dermatology clinics and primary care practices continue to manage chronic or complicated cases, especially where systemic antivirals or differential diagnosis are warranted. E-commerce growth and direct-to-consumer marketing are enabling pharmaceutical brands to target specific consumer segments with convenience-based subscription models, bundled offerings, and educational content designed to improve adherence and brand loyalty.

How Are Regulatory, Branding, and Pricing Strategies Shaping Competitive Positioning?

The cold sore treatment market is highly competitive, with numerous generic formulations and brand-name options competing on efficacy claims, speed of action, and user experience. Regulatory pathways vary across regions, with some antiviral treatments requiring prescriptions and others available OTC. This regulatory fragmentation influences pricing, marketing flexibility, and access across markets. Brands are differentiating through novel delivery formats, value-added ingredients like moisturizers or anesthetics, and clinician endorsements to reinforce credibility.

Pricing sensitivity is notable, especially in OTC segments, where consumer choices are influenced by perceived effectiveness, speed, and duration of relief. Companies are leveraging multi-channel branding strategies-combining in-store placement, influencer marketing, and digital health platforms-to build consumer trust and trigger impulse purchases during outbreak onset. As cold sore treatments shift further into self-care territory, packaging design, ease of application, and user education are playing increasingly important roles in brand preference and treatment adherence.

What Are the Factors Driving Growth in the Cold Sore Treatment Market?

Market growth is being driven by high global prevalence of HSV-1, increased consumer awareness, and a strong preference for fast-acting, accessible therapies that reduce lesion duration and visibility. The shift toward self-managed care, combined with rising comfort in purchasing health products online, is expanding demand across both established and emerging regions. Innovation in drug formulations, delivery systems, and adjunctive devices is enabling more tailored treatment experiences, especially for consumers managing frequent outbreaks.

As the stigma around cold sores continues to decline and product innovation accelerates, brands that can balance efficacy, discretion, and convenience will be best positioned for sustained market share. Whether treatment providers can further integrate digital health tools, improve access to targeted therapies, and align with evolving consumer expectations will shape the market’s next phase-where cold sore management becomes not just about symptom relief, but about proactive, confident personal care.

SCOPE OF STUDY:

The report analyzes the Cold Sore Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Topical Treatments, Oral Treatments, Light-based Treatments); Cold Sore Type (Primary Outbreaks, Recurrent Outbreaks); Age Group (Children, Adolescents, Adults); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Aurobindo Pharma Ltd.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Biofrontera AG
  • Bristol-Myers Squibb Company
  • Church & Dwight Co., Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Ferring Pharmaceuticals
  • GSK plc
  • Haleon plc
  • HRA Pharma
  • Johnson & Johnson
  • Meda Pharmaceuticals
  • Mylan N.V. (now part of Viatris Inc.)
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Product Code: MCP33639

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cold Sore Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Recurrence Rates of HSV-1 Infections Sustain Demand for Over-the-Counter and Prescription Cold Sore Treatments
    • Topical Antivirals and Moisturizing Agents Remain Mainstay Options in Early Symptom Management
    • Innovation in Patch-Based and Invisible Gel Formulations Enhances Discretion and Wearability
    • Online Dermatology Platforms and E-Pharmacies Expand Access to Cold Sore Therapy Products
    • Consumer Preference for Natural and Zinc-Based Remedies Supports Growth in Alternative Treatments
    • Mobile Apps With Flare-Up Trackers and Reminders Improve Adherence to Suppression Therapy
    • Prescription Therapies See Uptick in Use for Immunocompromised and High-Risk Populations
    • Cold Sore Treatment Bundles Including Lip Balms, Pain Relief, and Antiseptic Swabs Gain Popularity
    • Increased Awareness of Triggers Like Stress and Sun Exposure Drives Demand for Preventive Options
    • Packaging Innovation and Pocket-Sized Formats Cater to On-the-Go Use Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cold Sore Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cold Sore Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Topical Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Topical Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Topical Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Oral Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Oral Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Oral Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Light-based Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Light-based Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Light-based Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Online Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Primary Outbreaks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Primary Outbreaks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Primary Outbreaks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Recurrent Outbreaks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Recurrent Outbreaks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Recurrent Outbreaks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Children by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Children by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Children by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Adolescents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Adolescents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Adolescents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Adults by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • JAPAN
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • CHINA
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • EUROPE
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Cold Sore Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • FRANCE
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 101: France Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • GERMANY
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 137: UK Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Cold Sore Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • INDIA
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 212: India Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Cold Sore Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Cold Sore Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Cold Sore Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030
  • AFRICA
    • Cold Sore Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Cold Sore Treatment by Product Type - Topical Treatments, Oral Treatments and Light-based Treatments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Cold Sore Treatment by Product Type - Percentage Breakdown of Value Sales for Topical Treatments, Oral Treatments and Light-based Treatments for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Cold Sore Treatment by Distribution Channel - Retail Pharmacy, Online Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Cold Sore Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacy, Online Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Cold Sore Treatment by Cold Sore Type - Primary Outbreaks and Recurrent Outbreaks Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Cold Sore Treatment by Cold Sore Type - Percentage Breakdown of Value Sales for Primary Outbreaks and Recurrent Outbreaks for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Cold Sore Treatment by Age Group - Children, Adolescents and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Cold Sore Treatment by Age Group - Children, Adolescents and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Cold Sore Treatment by Age Group - Percentage Breakdown of Value Sales for Children, Adolescents and Adults for the Years 2015, 2025 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!